WO2002013846A3 - Antifungal combination therapy - Google Patents

Antifungal combination therapy Download PDF

Info

Publication number
WO2002013846A3
WO2002013846A3 PCT/JP2001/007009 JP0107009W WO0213846A3 WO 2002013846 A3 WO2002013846 A3 WO 2002013846A3 JP 0107009 W JP0107009 W JP 0107009W WO 0213846 A3 WO0213846 A3 WO 0213846A3
Authority
WO
WIPO (PCT)
Prior art keywords
combination therapy
antifungal combination
antifungal
granulocyte
stimulating factor
Prior art date
Application number
PCT/JP2001/007009
Other languages
French (fr)
Other versions
WO2002013846A2 (en
Inventor
Fumiaki Ikeda
Etsuko Watabe
Satoru Matsumoto
Tomoe Ushitani
Yasuto Koide
Original Assignee
Fujisawa Pharmaceutical Co
Fumiaki Ikeda
Etsuko Watabe
Satoru Matsumoto
Tomoe Ushitani
Yasuto Koide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co, Fumiaki Ikeda, Etsuko Watabe, Satoru Matsumoto, Tomoe Ushitani, Yasuto Koide filed Critical Fujisawa Pharmaceutical Co
Priority to EP01956880A priority Critical patent/EP1317277A2/en
Priority to JP2002518986A priority patent/JP2004506017A/en
Priority to US10/344,008 priority patent/US20040023858A1/en
Publication of WO2002013846A2 publication Critical patent/WO2002013846A2/en
Publication of WO2002013846A3 publication Critical patent/WO2002013846A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Packages (AREA)

Abstract

There is described antifungal combination use of Granulocyte-colony stimulating factor with a lipopeptide compound (I) as described herein.
PCT/JP2001/007009 2000-08-14 2001-08-13 Antifungal combination therapy WO2002013846A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01956880A EP1317277A2 (en) 2000-08-14 2001-08-13 Antifungal combination therapy
JP2002518986A JP2004506017A (en) 2000-08-14 2001-08-13 Use antifungal combination
US10/344,008 US20040023858A1 (en) 2000-08-14 2001-08-13 Antifungal combination therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ9387 2000-08-14
AUPQ9387A AUPQ938700A0 (en) 2000-08-14 2000-08-14 Antifungal combination use

Publications (2)

Publication Number Publication Date
WO2002013846A2 WO2002013846A2 (en) 2002-02-21
WO2002013846A3 true WO2002013846A3 (en) 2003-04-03

Family

ID=3823445

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/007009 WO2002013846A2 (en) 2000-08-14 2001-08-13 Antifungal combination therapy

Country Status (5)

Country Link
US (1) US20040023858A1 (en)
EP (1) EP1317277A2 (en)
JP (1) JP2004506017A (en)
AU (1) AUPQ938700A0 (en)
WO (1) WO2002013846A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7708701B2 (en) 2002-04-19 2010-05-04 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device
US7909778B2 (en) * 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
CN1295983C (en) * 2005-03-11 2007-01-24 浙江大学 Preparation method of enzyme enriched active yeast feed

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011210A1 (en) * 1994-10-07 1996-04-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011210A1 (en) * 1994-10-07 1996-04-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B.J. KULLBERG ET AL.: "Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 26, 1999, AMSTERDAM, NL, pages 299 - 307, XP002218423 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1996, HERBRECHT R ET AL: "Synergistic efficacy of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in non neutropenic mice.", XP002218424, Database accession no. PREV199699131029 *
JOURNAL DE MYCOLOGIE MEDICALE, vol. 6, no. 2, 1996, pages 43 - 48, ISSN: 1156-5233 *

Also Published As

Publication number Publication date
JP2004506017A (en) 2004-02-26
US20040023858A1 (en) 2004-02-05
WO2002013846A2 (en) 2002-02-21
EP1317277A2 (en) 2003-06-11
AUPQ938700A0 (en) 2000-09-07

Similar Documents

Publication Publication Date Title
AU2002359830A1 (en) Wound vacuum therapy dressing kit
AU2002322719A1 (en) Delivery of therapeutic capable agents
EP1193270A3 (en) Pyrrolobenzodiazepines
AU2001289640A1 (en) Intracardiac blood pump
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
AU2001256148A1 (en) Subcutaneous administration of coagulation factor vii
AU2002360599A1 (en) Portable massage chair
WO2002013846A3 (en) Antifungal combination therapy
AU2001272383A1 (en) Fungicidal combinations of active agents
AU2001243299A1 (en) Luminescent medical bandage
AU2001274649A1 (en) Topical preparation of alprostadil for the treatment of erectile dysfunction
AU2001236562A1 (en) Portable spa
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
DE50212646D1 (en) USE OF SELF-CONNECTIVE COMPOUNDS FOR TOPICAL OR BUCCAL APPLICATION
AUPQ866500A0 (en) Therapeutic compounds and methods
AU2001236671A1 (en) Spa with double sealed pump
IL147023A0 (en) Stable xylometazoline and oxymetazoline solution
CA97230S (en) Escutcheon
AU2003246614A1 (en) Novel use of lipopeptide preparations
AU2001290061A1 (en) Analogues of human granulocite colony stimulating factor (g-csf)
CA97229S (en) Escutcheon
AU2003281257A1 (en) A novel use of rapamycin and structural analogues thereof
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
NO20002428D0 (en) A skin preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002518986

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001956880

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10344008

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001956880

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001956880

Country of ref document: EP